Atlas Trials

IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.

Clinical trial NCT05191394 · COMPLETED

Trial details

NCT number
NCT05191394
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Therapeutic Plasma Exchange
Start date
2021-09-08
Primary completion
2022-02-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.